Aurobindo Pharma dips 5% on weak operational performance in June quarter ...Middle East

Aurobindo Pharma has entered into definitive agreements under which the Company will subscribe to fresh equity shares in Cronus amounting to Rs 420 crore

Hence then, the article about aurobindo pharma dips 5 on weak operational performance in june quarter was published today ( Friday 13/08/2021 - 07:30 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aurobindo Pharma dips 5% on weak operational performance in June quarter )

Also on site :

• STAG INDUSTRIAL TO REPORT FIRST QUARTER 2026 RESULTS
• Dodgers Claim Grant Holman From D-Backs
• Trump economic approval tanks